Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMORE.L Regulatory News (MORE)

  • There is currently no data for MORE

Director/PDMR Shareholding

31 May 2023 09:57

RNS Number : 1687B
Hostmore PLC
31 May 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

31 May 2023

 

 

Hostmore plc

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Grant of Restricted Share Award

Hostmore plc (the "Company") announces that the following restricted share award over ordinary shares of 20 pence each in the Company was granted to Julie McEwan, a Person Discharging Managerial Responsibilities ("PDMR"), to reflect the additional responsibilities of her acting as the Company's permanent Chief Executive Officer. It was agreed at the time Julie McEwan was appointed as permanent Chief Executive Officer that this award over shares in the Company would be made to her. The vesting of the restricted share award is subject to the approval of the Company's new Directors' Remuneration Policy by the requisite proportion of the Company's shareholders at the Company's annual general meeting on 7 June 2023. Subject to the aforementioned condition being satisfied, these shares will be transferred to Julie McEwan by Intertrust Employee Benefit Trustee Limited, the trustee of the Hostmore plc 2021 Employee Benefit Trust, from shares currently held by the Trust.

Participant

Position

No. of Shares under Award

Julie McEwan

Chief Executive Officer

185,000

 

The award was granted as a restricted share award on 30 May 2023. The vesting of the award is subject to the approval of the Company's new Directors' Remuneration Policy by the requisite proportion of the Company's shareholders at the Company's annual general meeting on 7 June 2023. A two-year holding period applies to the shares.

The grant of the award has been made as outlined and in accordance with the Directors' Remuneration Policy published in the Company's annual report and financial statements for the 52-week period ended 1 January 2023.

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Full Name

Julie McEwan

2.

Reasons for the notification

a)

Position / status

Chief Executive Officer

 

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Hostmore plc

 

b)

Legal Entity Identifier code

2138008IAVFFCVTG1L66

 

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Grant of restricted share award over ordinary shares of £0.20 each

 

 

GB00BMV9MD66

 

b)

Nature of the transaction

Grant of restricted share award

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

Grant

 

Nil

 

185,000

d)

Aggregated information

- Aggregated volume

- Price

Not Applicable

e)

Date of the transaction

 

30 May 2023

f)

Place of the transaction

 

Outside a trading venue

 

ENQUIRIES

Hostmore plc

Alan Clark, Chief Financial Officer

enquiries@hostmoregroup.com

+44 330 460 5588

 

Dentons Global Advisors

Jonathon Brill / James Styles

Hostmore@dentonsglobaladvisors.com

Tel: +44 (0)20 7664 509

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHWPUQAAUPWURG
Date   Source Headline
7th Jun 20237:01 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSAGM Trading Update
5th Jun 202311:03 amRNSIntended Purchase of Shares by CEO
5th Jun 20237:00 amRNSDirectorate Appointment
31st May 20239:57 amRNSDirector/PDMR Shareholding
17th May 20235:30 pmRNSDirector/PDMR Shareholding
17th May 202310:56 amRNSDirector/PDMR Shareholding
12th May 20235:29 pmRNSDirector/PDMR Shareholding
12th May 202311:58 amRNSHolding(s) in Company
10th May 20235:59 pmRNSHolding(s) in Company
3rd May 20236:29 pmRNSNotification of transactions by PDMR
2nd May 20237:00 amRNSCost Reduction Programme, CEO Appointment, Webcast
28th Apr 20236:23 pmRNSFinal Results
29th Mar 20231:25 pmRNSHolding(s) in Company
14th Mar 20234:24 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSRevised Results Publication Date & Trading Update
27th Feb 20234:35 pmRNSPrice Monitoring Extension
24th Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSDirectorate Change
10th Jan 20237:00 amRNSTrading Update and Board Change
19th Dec 20226:16 pmRNSDirectorate Change
16th Dec 20229:17 amRNSHolding(s) in Company
13th Dec 20225:53 pmRNSDirectorate Change
8th Dec 202210:00 amRNSDirector/PDMR Shareholding
29th Nov 202211:24 amRNSHolding(s) in Company
29th Nov 202210:38 amRNSDirector/PDMR Shareholding
9th Nov 20227:00 amRNSLaunch of major new marketing campaign
8th Nov 202210:38 amRNSHolding(s) in Company
18th Oct 20224:40 pmRNSSecond Price Monitoring Extn
18th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20223:28 pmRNSDirector/PDMR Shareholding
27th Sep 20226:31 pmRNSDirector/PDMR Shareholding
26th Sep 20226:28 pmRNSHolding(s) in Company
26th Sep 20225:35 pmRNSHolding(s) in Company
26th Sep 20227:30 amRNSDirector/PDMR Shareholding
23rd Sep 202212:56 pmRNSHolding(s) in Company
22nd Sep 20224:02 pmRNSDirector/PDMR Shareholding
22nd Sep 20229:09 amRNSDirector/PDMR Shareholding
21st Sep 20227:00 amRNSInterim Results
12th Sep 20223:45 pmRNSNotice of Interim Results - Update
30th Aug 20221:02 pmRNSNotice of Interim Results
26th Aug 20229:58 amRNSHolding(s) in Company
25th Aug 20225:08 pmRNSHolding(s) in Company
23rd Aug 20221:55 pmRNSHolding(s) in Company
16th Aug 20229:38 amRNSDirectorate Change
21st Jul 202210:40 amRNSPurchase of Shares by EBT
11th Jul 20225:22 pmRNSHolding(s) in Company - Amendment (1 July 2022)
11th Jul 20227:00 amRNSTrading update for the 26 weeks ended 3 July 2022
1st Jul 20222:54 pmRNSHolding(s) in Company
30th Jun 20225:25 pmRNSIntended Purchase of Shares by EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.